Contribution: Industrial Research Assistance Program – Contributions to Firms
Altis Labs, Inc
$45,000.00
Augmentation for Cardiovascular Disease in Lung Cancer Patients
FY 2020-21 · 2020-09-08
Summary
Altis Labs is creating a cardiac mortality risk score from patient chest CTs to increase awareness of patient’s risk of cardiovascular death. Cardiovascular death is the second highest cause of death in patients diagnosed with cancer
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
703643080
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-09-08 | 2020-21 | $53,000.00 |
| 1 | 2020-09-08 | 2020-21 | $45,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 75 days. The total amended value is -8,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 75 jours. La valeur totale des modifications est de - 8 000 dollars.
Agreement End Date
2021-05-31
Agreement Number
956074
Agreement Start Date
2020-09-08
Agreement Title
Augmentation for Cardiovascular Disease in Lung Cancer Patients
Agreement Title (French)
Augmentation des maladies cardiovasculaires chez les patients atteints d'un cancer du poumon
Agreement Type
Contribution
Agreement Value
$45,000.00
Amendment Date
2021-01-18
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Altis Labs is creating a cardiac mortality risk score from patient chest CTs to increase awareness of patient’s risk of cardiovascular death. Cardiovascular death is the second highest cause of death in patients diagnosed with cancer
Description (French)
Altis Labs est en train de créer un score de risque de mortalité cardiaque à partir de scanners thoraciques des patients afin d'accroître la sensibilisation au risque de décès cardiovasculaire des patients. La mort cardiovasculaire est la deuxième cause de décès chez les patients atteints d'un cancer.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Toronto Centre
Federal Riding (French)
Toronto-Centre
Federal Riding Number
35108
NAICS Code
511211
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
703643080
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
Altis Labs, Inc
Recipient Operating Name
Altis Labs
Recipient Postal Code
M4Y 0C4
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2020-2021-Q2-956074
